Cargando…
Coronary vasospasm during infusion of CD-19 directed chimeric antigen receptor T-cell therapy: a case report
BACKGROUND: Cardiovascular events have been reported to occur in one in five patients receiving chimeric antigen receptor T-cell (CAR-T) therapy. Commonly reported effects including cardiomyopathy, heart failure, myocardial infarction (MI), and arrhythmia. Here, we present a novel case of a patient...
Autores principales: | Tao, Jacqueline J, Roszkowska, Natalia, Majure, David T, Mahmood, Syed S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398419/ https://www.ncbi.nlm.nih.gov/pubmed/37547374 http://dx.doi.org/10.1093/ehjcr/ytad342 |
Ejemplares similares
-
A Case of Coronary Vasospasm after Repeat Rituximab Infusion
por: Ke, Calvin, et al.
Publicado: (2015) -
Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy
por: Lipe, Demis N., et al.
Publicado: (2023) -
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
por: Hu, Yongxian, et al.
Publicado: (2016) -
Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023) -
Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
por: Tang, Fang, et al.
Publicado: (2020)